Camber Capital Management as of March 31, 2017
Portfolio Holdings for Camber Capital Management
Camber Capital Management holds 31 positions in its portfolio as reported in the March 2017 quarterly 13F filing
Company (Ticker) |
Portfolio Weight |
Valued At |
Change in Shares |
Share Count |
Share Price |
---|---|---|---|---|---|
Spdr S&p 500 Etf (SPY) | 28.8 | $707M | 3.0M | 235.74 | |
Gilead Sciences (GILD) | 8.0 | $197M | 2.9M | 67.92 | |
Teva Pharmaceutical Industries (TEVA) | 6.8 | $167M | 5.2M | 32.09 | |
Mylan Nv | 6.6 | $162M | 4.1M | 38.99 | |
Nektar Therapeutics (NKTR) | 5.2 | $127M | 5.4M | 23.47 | |
Allergan | 4.2 | $104M | 436k | 238.92 | |
Myriad Genetics (MYGN) | 3.4 | $83M | 4.3M | 19.20 | |
Genomic Health | 3.1 | $77M | 2.5M | 31.49 | |
Brookdale Senior Living (BKD) | 3.0 | $74M | 5.5M | 13.43 | |
Vertex Pharmaceuticals Incorporated (VRTX) | 2.9 | $71M | 650k | 109.35 | |
Select Medical Holdings Corporation (SEM) | 2.7 | $67M | 5.0M | 13.35 | |
Bioverativ Inc Com equity | 2.4 | $60M | 1.1M | 54.46 | |
Livanova Plc Ord (LIVN) | 2.4 | $59M | 1.2M | 49.01 | |
Orthofix International Nv Com Stk | 2.3 | $57M | 1.5M | 38.15 | |
Endo International | 2.3 | $56M | 5.1M | 11.16 | |
Perrigo Company (PRGO) | 2.2 | $54M | 808k | 66.39 | |
Cardiovascular Systems | 2.0 | $50M | 1.8M | 28.27 | |
Abbott Laboratories (ABT) | 1.8 | $44M | 1.0M | 44.41 | |
Endologix | 1.8 | $43M | 6.0M | 7.24 | |
Alkermes (ALKS) | 1.7 | $42M | 725k | 58.50 | |
Sarepta Therapeutics (SRPT) | 1.6 | $40M | 1.4M | 29.60 | |
Invitae (NVTAQ) | 1.1 | $27M | 2.4M | 11.06 | |
Syneron Medical Ltd ord | 1.0 | $25M | 2.3M | 10.55 | |
Puma Biotechnology (PBYI) | 1.0 | $24M | 650k | 37.20 | |
BioScrip | 0.7 | $17M | 10M | 1.70 | |
Ptc Therapeutics I (PTCT) | 0.5 | $12M | 1.3M | 9.84 | |
Arena Pharmaceuticals | 0.2 | $6.2M | 4.3M | 1.46 | |
Atara Biotherapeutics | 0.1 | $2.6M | 125k | 20.55 | |
Targacept Inc Conv Dtd convertible | 0.1 | $1.7M | 1.7M | 1.00 | |
Dextera Surgical | 0.0 | $888k | 838k | 1.06 | |
Biolase Technology | 0.0 | $0 | 7.2M | 0.00 |